Chapel Hill startup with ties to UNC lands rights to drug offering hope to cystic fibrosis patients

Posted Oct 27, 2019
Path BioAnalytics (PBA), a precision medicine startup with ties to UNC, has scored the rights to a new drug therapy offering hope to cystic fibrosis (CF) patients with rare mutations. PBA is a graduate of Launch Chapel Hill, an accelerator program based in Chapel Hill, as well as the Kenan Flagler Business School program Startup UNC. (WRAL Tech Wire)

Related: Campus Connections

Chansky’s Notebook: Game Changer
“Boo-Yah” to the Carolina guy who popularized the word. ESPN’s 30 for 30 special on Stuart Scott will make you laugh and wonder how he...
Thu Dec 11, 2025

Beyond Boo-Yah: How Stuart Scott’s friends carry his memory to this day
What comes to mind when you hear the name Stuart Scott? For Roy Williams, it’s as simple as a smile. "That’s the best thing...that’s a...
Wed Dec 10, 2025

Filmmaker Andre Gaines on ‘the honor’ of making a Stuart Scott 30 for 30
In ESPN’s history, few SportsCenter anchors have become cultural icons. UNC alumnus Stuart Scott persevered to become one of The Worldwide Leader in Sports’ most...
Tue Dec 9, 2025

Stuart Scott 30 for 30 showcases ESPN legend who changed the game
Stuart Scott is the subject of ESPN’s latest 30 for 30 film: “Boo-Yah: A Portrait of Stuart Scott,” which premieres on Dec. 10 at 9...
Mon Dec 8, 2025